Daniel Peterson: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - "|author-link6=}}" to "}}") |
Notjusttired (talk | contribs) m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author") |
||
Line 83: | Line 83: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Alter, et al, 2012">{{Citation | <ref name="Alter, et al, 2012">{{Citation |last1 = Alter |first 1 |authorlink1 = |last2 = Mikovits |first 2 |authorlink2 = Judy Mikovits |last3 = Switzer |first 3 |authorlink3 = |last4 = Ruscetti |first 4 |authorlink4 = |last5 = Lo |first 5 |authorlink5 = |last6 = Klimas |first 6 |authorlink6 = Nancy Klimas |last7 = Komaroff |first 7 |authorlink7 = Anthony Komaroff |last8 = Montoya |first 8 |authorlink8 = Jose Montoya |last9 = Bateman |first 9 |authorlink9 = Lucinda Bateman |last10 = Levine |first 10 |authorlink10 = Susan Levine |last11 = Peterson |first 11 |authorlink11 = Daniel Peterson |last12 = Levin |first 12 |authorlink12 = Bruce Levin |last13 = Hanson |first 13 |authorlink13 = Maureen Hanson |last14 = Genfi |first 14 |authorlink14 = |last15 = Bhat |first 15 |authorlink15 = |last16 = Zheng |first 16 |authorlink16 = |last17 = Wang |first 17 |authorlink17 = |last18 = Li |first 18 |authorlink18 = |last19 = Hung |first 19 |authorlink19 = |last20 = Lee |first 20 |authorlink20 = |last21 = Sameroff |first 21 |authorlink21 = |last22 = Heneine |first 22 |authorlink22 = |last23 = Coffin |first 23 |authorlink23 = |last24 = Hornig |first 24 |authorlink24 = Mady Hornig |last25 = Lipkin |first 25 |authorlink25 = Ian Lipkin | ||
| last1 = Alter | |||
| last2 = Mikovits | |||
| last3 = Switzer | |||
| last4 = Ruscetti | |||
| last5 = Lo | |||
| last6 = Klimas | |||
| last7 = Komaroff | |||
| last8 = Montoya | |||
| last9 = Bateman | |||
| last10 = Levine | |||
| last11 = Peterson | |||
| last12 = Levin | |||
| last13 = Hanson | |||
| last14 = Genfi | |||
| last15 = Bhat | |||
| last16 = Zheng | |||
| last17 = Wang | |||
| last18 = Li | |||
| last19 = Hung | |||
| last20 = Lee | |||
| last21 = Sameroff | |||
| last22 = Heneine | |||
| last23 = Coffin | |||
| last24 = Hornig | |||
| last25 = Lipkin | |||
| title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | | title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | ||
| journal = mBio | volume = 3 | issue = 5 | page = e00266–12 | | journal = mBio | volume = 3 | issue = 5 | page = e00266–12 | ||
Line 116: | Line 91: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="BatemanL, 2015">{{Citation | <ref name="BatemanL, 2015">{{Citation |last1 = Bateman |first 1 |authorlink1 = Lucinda Bateman |last2 = Darakjy |first 2 |authorlink2 = |last3 = Klimas |first 3 |authorlink3 = Nancy Klimas |last4 = Peterson |first 4 |authorlink4 = Daniel Peterson |last5 = Levine |first 5 |authorlink5 = Susan Levine |last6 = Allen |first 6 |authorlink6 = |last7 = Carlson |first 7 |authorlink7 = |last8 = Balbin |first 8 |authorlink8 = Elizabeth Balbin |last9 = Gottschalk |first 9 |authorlink9 = Gunnar Gottschalk |last10 = March |first 10 |authorlink10 = | ||
| last1 = Bateman | |||
| last2 = Darakjy | |||
| last3 = Klimas | |||
| last4 = Peterson | |||
| last5 = Levine | |||
| last6 = Allen | |||
| last7 = Carlson | |||
| last8 = Balbin | |||
| last9 = Gottschalk | |||
| last10 = March | |||
| title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | | title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | ||
Line 134: | Line 99: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Buchwald, 1992">{{Citation | <ref name="Buchwald, 1992">{{Citation |last1 = Buchwald |first 1 |authorlink1 = Dedra Buchwald |last2 = Cheney |first 2 |authorlink2 = Paul Cheney |last3 = Peterson |first 3 |authorlink3 = Daniel Peterson |last4 = Henry |first 4 |authorlink4 = |last5 = Wormsley |first 5 |authorlink5 = |last6 = Geiger |first 6 |authorlink6 = |last7 = Ablashi |first 7 |authorlink7 = Dharam Ablashi |last8 = Salahuddin |first 8 |authorlink8 = |last9 = Saxinger |first 9 |authorlink9 = |last10 = Biddle |first 10 |authorlink10 = |last11 = Kikinis |first 11 |authorlink11 = |last12 = Jolesz |first 12 |authorlink12 = |last13 = Folks |first 13 |authorlink13 = |last14 = Balachandran |first 14 |authorlink14 = |last15 = Peter |first 15 |authorlink15 = |last16 = Gallo |first 16 |authorlink16 = |last17 = Komaroff |first 17 |authorlink17 = Anthony Komaroff | ||
| last1 = Buchwald | |||
| last2 = Cheney | |||
| last3 = Peterson | |||
| last4 = Henry | |||
| last5 = Wormsley | |||
| last6 = Geiger | |||
| last7 = Ablashi | |||
| last8 = Salahuddin | |||
| last9 = Saxinger | |||
| last10 = Biddle | |||
| last11 = Kikinis | |||
| last12 = Jolesz | |||
| last13 = Folks | |||
| last14 = Balachandran | |||
| last15 = Peter | |||
| last16 = Gallo | |||
| last17 = Komaroff | |||
| title = A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection | | title = A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection | ||
| journal = Annals of Internal Medicine | volume = 116 | issue = 2 | page = 103-113 | | journal = Annals of Internal Medicine | volume = 116 | issue = 2 | page = 103-113 | ||
Line 158: | Line 106: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Hornig, 2016">{{Citation | <ref name="Hornig, 2016">{{Citation |last1 = Hornig |first 1 |authorlink1 = Mady Hornig |last2 = Gottschalk |first 2 |authorlink2 = Gunnar Gottschalk |last3 = Peterson |first 3 |authorlink3 = Daniel Peterson |last4 = Knox |first 4 |authorlink4 = |last5 = Schultz |first 5 |authorlink5 = |last6 = Eddy |first 6 |authorlink6 = |last7 = Che |first 7 |authorlink7 = |last8 = Lipkin |first 8 |authorlink8 = Ian Lipkin | ||
| last1 = Hornig | |||
| last2 = Gottschalk | |||
| last3 = Peterson | |||
| last4 = Knox | |||
| last5 = Schultz | |||
| last6 = Eddy | |||
| last7 = Che | |||
| last8 = Lipkin | |||
| title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | | title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | ||
| journal = Molecular Psychiatry | volume = 21 | issue = 2 | page = 261-9 | | journal = Molecular Psychiatry | volume = 21 | issue = 2 | page = 261-9 | ||
Line 173: | Line 113: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Hornig, 2017">{{Citation | <ref name="Hornig, 2017">{{Citation |last1 = Hornig |first 1 |authorlink1 = Mady Hornig |last2 = Gottschalk |first 2 |authorlink2 = Gunnar Gottschalk |last3 = Eddy |first 3 |authorlink3 = |last4 = Che |first 4 |authorlink4 = |last5 = Ukaigwe |first 5 |authorlink5 = |last6 = Peterson |first 6 |authorlink6 = Daniel Peterson |last7 = Lipkin |first 7 |authorlink7 = Ian Lipkin | ||
| last1 = Hornig | |||
| last2 = Gottschalk | |||
| last3 = Eddy | |||
| last4 = Che | |||
| last5 = Ukaigwe | |||
| last6 = Peterson | |||
| last7 = Lipkin | |||
| title = Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations | | title = Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations | ||
| journal = Translational Psychiatry | volume = 7 | issue = 4 | page = | | journal = Translational Psychiatry | volume = 7 | issue = 4 | page = | ||
Line 187: | Line 120: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="KlimasNG, 2015">{{Citation | <ref name="KlimasNG, 2015">{{Citation |last1 = Klimas |first 1 |authorlink1 = Nancy Klimas |last2 = Ironson |first 2 |authorlink2 = |last3 = Carter |first 3 |authorlink3 = |last4 = Balbin |first 4 |authorlink4 = Elizabeth Balbin |last5 = Bateman |first 5 |authorlink5 = Lucinda Bateman |last6 = Felsenstein |first 6 |authorlink6 = Donna Felsenstein |last7 = Levine |first 7 |authorlink7 = Susan Levine |last8 = Peterson |first 8 |authorlink8 = Daniel Peterson |last9 = Chiu |first 9 |authorlink9 = |last10 = Allen |first 10 |authorlink10 = |last11 = Cunningham |first 11 |authorlink11 = |last12 = Gottschalk |first 12 |authorlink12 = Gunnar Gottschalk |last13 = Fletcher |first 13 |authorlink13 = Mary Ann Fletcher |last14 = Hornig |first 14 |authorlink14 = Mady Hornig |last15 = Canning |first 15 |authorlink15 = |last16 = Komaroff |first 16 |authorlink16 = Anthony Komaroff | ||
| last1 = Klimas | |||
| last2 = Ironson | |||
| last3 = Carter | |||
| last4 = Balbin | |||
| last5 = Bateman | |||
| last6 = Felsenstein | |||
| last7 = Levine | |||
| last8 = Peterson | |||
| last9 = Chiu | |||
| last10 = Allen | |||
| last11 = Cunningham | |||
| last12 = Gottschalk | |||
| last13 = Fletcher | |||
| last14 = Hornig | |||
| last15 = Canning | |||
| last16 = Komaroff | |||
| title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | ||
Line 211: | Line 128: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Levine, 1992">{{Citation | <ref name="Levine, 1992">{{Citation |last1 = Levine |first 1 |authorlink1 = Paul Levine |last2 = Jacobson |first 2 |authorlink2 = |last3 = Pocinki |first 3 |authorlink3 = Alan Pocinki |last4 = Cheney |first 4 |authorlink4 = Paul Cheney |last5 = Peterson |first 5 |authorlink5 = Daniel Peterson |last6 = Connelly |first 6 |authorlink6 = |last7 = Weil |first 7 |authorlink7 = |last8 = Robinson |first 8 |authorlink8 = |last9 = Ablashi |first 9 |authorlink9 = Dharam Ablashi | ||
| last1 = Levine | | last10 = Salahuddin | first10 = Sayeef Z | authorlink10 = |last11 = Pearson |first 11 |authorlink11 = |last12 = Hoover |first 12 |authorlink12 = | ||
| last2 = Jacobson | |||
| last3 = Pocinki | |||
| last4 = Cheney | |||
| last5 = Peterson | |||
| last6 = Connelly | |||
| last7 = Weil | |||
| last8 = Robinson | |||
| last9 = Ablashi | |||
| last10 = Salahuddin | first10 = Sayeef Z | authorlink10 = | |||
| last11 = Pearson | |||
| last12 = Hoover | |||
| title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | | title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | ||
| journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | | journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | ||
Line 231: | Line 137: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Levine, 2000">{{Citation | <ref name="Levine, 2000">{{Citation |last1 = Levine |first 1 |authorlink1 = Paul Levine |last2 = Pilkington |first 2 |authorlink2 = |last3 = Strickland |first 3 |authorlink3 = |last4 = Peterson |first 4 |authorlink4 = Daniel Peterson | ||
| last1 = Levine | |||
| last2 = Pilkington | |||
| last3 = Strickland | |||
| last4 = Peterson | |||
| title = Chronic Fatigue Syndrome and Cancer | | title = Chronic Fatigue Syndrome and Cancer | ||
| journal = Journal of Chronic Fatigue Syndrome | volume = 7 | issue = 1 | page = 29-38 | | journal = Journal of Chronic Fatigue Syndrome | volume = 7 | issue = 1 | page = 29-38 | ||
Line 243: | Line 145: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Nagy-Szakal, 2017">{{Citation | <ref name="Nagy-Szakal, 2017">{{Citation |last1 = Nagy-Szakal |first 1 |authorlink1 = Dorottya Nagy-Szakal |last2 = Williams |first 2 |authorlink2 = |last3 = Mishra |first 3 |authorlink3 = |last4 = Che |first 4 |authorlink4 = |last5 = Lee |first 5 |authorlink5 = |last6 = Bateman |first 6 |authorlink6 = Lucinda Bateman |last7 = Klimas |first 7 |authorlink7 = Nancy Klimas |last8 = Komaroff |first 8 |authorlink8 = Anthony Komaroff |last9 = Levine |first 9 |authorlink9 = Susan Levine |last10 = Montoya |first 10 |authorlink10 = Jose Montoya |last11 = Peterson |first 11 |authorlink11 = Daniel Peterson |last12 = Ramanan |first 12 |authorlink12 = |last13 = Jain |first 13 |authorlink13 = |last14 = Eddy |first 14 |authorlink14 = |last15 = Hornig |first 15 |authorlink15 = Mady Hornig |last16 = Lipkin |first 16 |authorlink16 = Ian Lipkin | ||
| last1 = Nagy-Szakal | |||
| last2 = Williams | |||
| last3 = Mishra | |||
| last4 = Che | |||
| last5 = Lee | |||
| last6 = Bateman | |||
| last7 = Klimas | |||
| last8 = Komaroff | |||
| last9 = Levine | |||
| last10 = Montoya | |||
| last11 = Peterson | |||
| last12 = Ramanan | |||
| last13 = Jain | |||
| last14 = Eddy | |||
| last15 = Hornig | |||
| last16 = Lipkin | |||
| title = Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome | | title = Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome | ||
| journal = Microbiome | volume = 5 | issue = 44 | page = | | journal = Microbiome | volume = 5 | issue = 44 | page = | ||
Line 267: | Line 153: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Nagy-Szakal, 2018">{{Citation | <ref name="Nagy-Szakal, 2018">{{Citation |last1 = Nagy-Szakal |first 1 |authorlink1 = Dorottya Nagy-Szakal |last2 = Barupal |first 2 |authorlink2 = |last3 = Lee |first 3 |authorlink3 = |last4 = Che |first 4 |authorlink4 = |last5 = Williams |first 5 |authorlink5 = |last6 = Kahn |first 6 |authorlink6 = |last7 = Ukaigwe |first 7 |authorlink7 = |last8 = Bateman |first 8 |authorlink8 = Lucinda Bateman |last9 = Klimas |first 9 |authorlink9 = Nancy Klimas |last10 = Komaroff |first 10 |authorlink10 = Anthony Komaroff |last11 = Levine |first 11 |authorlink11 = Susan Levine |last12 = Montoya |first 12 |authorlink12 = Jose Montoya |last13 = Peterson |first 13 |authorlink13 = Daniel Peterson |last14 = Levin |first 14 |authorlink14 = Bruce Levin |last15 = Hornig |first 15 |authorlink15 = Mady Hornig |last16 = Fiehn |first 16 |authorlink16 = |last17 = Lipkin |first 17 |authorlink17 = Ian Lipkin | ||
| last1 = Nagy-Szakal | |||
| last2 = Barupal | |||
| last3 = Lee | |||
| last4 = Che | |||
| last5 = Williams | |||
| last6 = Kahn | |||
| last7 = Ukaigwe | |||
| last8 = Bateman | |||
| last9 = Klimas | |||
| last10 = Komaroff | |||
| last11 = Levine | |||
| last12 = Montoya | |||
| last13 = Peterson | |||
| last14 = Levin | |||
| last15 = Hornig | |||
| last16 = Fiehn | |||
| last17 = Lipkin | |||
| title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | | title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | ||
| journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | | journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | ||
Line 292: | Line 161: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Peterson, 2015">{{Citation | <ref name="Peterson, 2015">{{Citation |last1 = Peterson |first 1 |authorlink1 = Daniel Peterson |last2 = Brenu |first 2 |authorlink2 = Ekua Brenu |last3 = Gottschalk |first 3 |authorlink3 = Gunnar Gottschalk |last4 = Ramos |first 4 |authorlink4 = Sandra Ramos |last5 = Nguyen |first 5 |authorlink5 = |last6 = Staines |first 6 |authorlink6 = Donald Staines | ||
| last1 = Peterson | |||
| last2 = Brenu | |||
| last3 = Gottschalk | |||
| last4 = Ramos | |||
| last5 = Nguyen | |||
| last6 = Staines | |||
| last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | | last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | ||
| title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | | title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | ||
Line 306: | Line 169: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Strayer,1995">{{Citation | <ref name="Strayer,1995">{{Citation |last1 = Strayer |first 1 |authorlink1 = David Strayer |last2 = Carter |first 2 |authorlink2 = William Carter |last3 = Strauss |first 3 |authorlink3 = Kenneth Strauss |last4 = Brodsky |first 4 |authorlink4 = |last5 = Suhadolnik |first 5 |authorlink5 =Robert Suhadolnik |last6 = Ablashi |first 6 |authorlink6 = Dharam Ablashi |last7 = Henry |first 7 |authorlink7 = |last8 = Mitchell |first 8 |authorlink8 = William Mitchell |last9 = Bastien |first 9 |authorlink9 =Sheila Bastien |last10 = Peterson |first 10 |authorlink10 = Daniel Peterson | ||
| last1 = Strayer | |||
| last2 = Carter | |||
| last3 = Strauss | |||
| last4 = Brodsky | |||
| last5 = Suhadolnik | |||
| last6 = Ablashi | |||
| last7 = Henry | |||
| last8 = Mitchell | |||
| last9 = Bastien | |||
| last10 = Peterson | |||
| title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | | title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | ||
| journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | | journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | ||
Line 323: | Line 176: | ||
|url=|pages=|chapter=|edition=|isbn=}} | |url=|pages=|chapter=|edition=|isbn=}} | ||
</ref> | </ref> | ||
<ref name="Strayer, 2012">{{Citation | <ref name="Strayer, 2012">{{Citation |last1 = Strayer |first 1 |authorlink1 = David Strayer |last2 = Carter |first 2 |authorlink2 = William Carter |last3 = Stouch |first 3 |authorlink3 = |last4 = Stevens |first 4 |authorlink4 = Staci Stevens |last5 = Bateman |first 5 |authorlink5 = Lucinda Bateman |last6 = Cimoch |first 6 |authorlink6 = |last7 = Lapp |first 7 |authorlink7 =Charles Lapp |last8 = Peterson |first 8 |authorlink8 = Daniel Peterson | ||
| last1 = Strayer | | last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = |last10 = Mitchell |first 10 |authorlink10 = William Mitchell | ||
| last2 = Carter | |||
| last3 = Stouch | |||
| last4 = Stevens | |||
| last5 = Bateman | |||
| last6 = Cimoch | |||
| last7 = Lapp | |||
| last8 = Peterson | |||
| last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | |||
| last10 = Mitchell | |||
| title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | | title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | ||
| journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | | journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | ||
Line 341: | Line 185: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Unger, 2017">{{Citation | <ref name="Unger, 2017">{{Citation |last1 = Unger |first 1 |authorlink1 = Elizabeth Unger |last2 = Lin |first 2 |authorlink2 = Jin-Mann Sally Lin |last3 = Tian |first 3 |authorlink3 = |last4 = Natelson |first 4 |authorlink4 = Benjamin Natelson |last5 = Lange |first 5 |authorlink5 = Gudrun Lange |last6 = Vu |first 6 |authorlink6 = |last7 = Blate |first 7 |authorlink7 = |last8 = Klimas |first 8 |authorlink8 = Nancy Klimas |last9 = Balbin |first 9 |authorlink9 = Elizabeth Balbin |last10 = Bateman |first 10 |authorlink10 = Lucinda Bateman |last11 = Allen |first 11 |authorlink11 = |last12 = Lapp |first 12 |authorlink12 = Charles Lapp |last13 = Springs |first 13 |authorlink13 = |last14 = Kogelnik |first 14 |authorlink14 = Andreas Kogelnik |last15 = Phan |first 15 |authorlink15 = |last16 = Danver |first 16 |authorlink16 = |last17 = Podell |first 17 |authorlink17 = Richard Podell | ||
| last1 = Unger | | last18 = Fitzpatrick | first18 = Trisha | authorlink18 = |last19 = Peterson |first 19 |authorlink19 = Daniel Peterson | ||
| last2 = Lin | |||
| last3 = Tian | |||
| last4 = Natelson | |||
| last5 = Lange | |||
| last6 = Vu | |||
| last7 = Blate | |||
| last8 = Klimas | |||
| last9 = Balbin | |||
| last10 = Bateman | |||
| last11 = Allen | |||
| last12 = Lapp | |||
| last13 = Springs | |||
| last14 = Kogelnik | |||
| last15 = Phan | |||
| last16 = Danver | |||
| last17 = Podell | |||
| last18 = Fitzpatrick | first18 = Trisha | authorlink18 = | |||
| last19 = Peterson | |||
| last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | ||
| last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan |
Revision as of 03:47, May 11, 2022
Daniel L. Peterson, MD, is a physician in Incline Village, Nevada specializing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He was at the epicenter of the 1984 Incline Village chronic fatigue syndrome outbreak[1] and continues to be a leader in treatment and research about ME/CFS, serving on Simmaron Research’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at Griffith University in Queensland, Australia.[2]
He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the Nevada Center for Biomedical Research.[3] He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.[4] In 2019, he joined the scientific advisory board of the Open Medicine Foundation.[5]
Dr. Peterson was the first physician to use Ampligen, an immunomodulator made by AIM ImmunoTech (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on Nancy Kaiser, a very severe patient.[6] He has participated in every Ampligen trial since, up to the AMP-511, open label, cost-recovery trial available today.[7]
Several documentaries about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have featured Dr. Peterson, including, I Remember Me and Forgotten Plague, and the news feature, Sick and Tired.
Awards[edit | edit source]
- 2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by IACFS/ME[8]
- 2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by IACFS/ME[8]
Writing committees[edit | edit source]
- 2003, Canadian Consensus Criteria - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[9] (Full Text)
- 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[10]
Notable studies[edit | edit source]
- 1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection[11] (Abstract)
- 1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome[12] (Abstract - can request full article)
- 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen[13] (Abstract)
- 1997, Editorial - Chronic Fatigue Syndrome and Disability[14] (Abstract)
- 2000, Chronic Fatigue Syndrome and Cancer[15] (Abstract)
- 2001, Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an Outbreak [16] (Abstract)
- 2003, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[17] (Full Text)
- 2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway[18] (Full Text)
- 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus[19] (Abstract)
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[20] (Full Text)
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[21] (Full Text)
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[22] (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[23] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[24] (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[25] - (Full text)
- 2016, Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome[26] (Abstract)
- 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[27] (Full Text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[28] (Full Text)
- 2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations[29] (Full Text)
- 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[30] (Full text)
- 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics[31] (Full Text)
- 2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations[32] - (Full text)
Talks and interviews[edit | edit source]
ME/CFS Alert[edit | edit source]
- 2012, Episode 26, ME/CFS Alert interview
- 2013, Episode 50, ME/CFS Alert interview
Invest in ME International ME Conference[edit | edit source]
- 2007, Speaker on Day 1 of the 2nd Invest in ME International ME Conference on Experiences of Research into ME/CFS: Past, Present, and Future - (Video)
- 2007, Speaker on Day 2 of the 2nd Invest in ME International ME Conference on Clinical Research - (Video)
- 2009, Speaker at the 4th Invest in ME International ME Conference on Treatment Regimes for the Most Severe Cases[33] DVD available
- 2012, Speaker at the 7th Invest in ME International ME Conference on Clinical Research Update 2012[34] DVD available
- 2013, Speaker at the 8th Invest in ME International ME Conference on Key Note Speech: The Mainstreaming of ME Research[35] DVD available
Other[edit | edit source]
- 1996, Primetime Live TV Show - Sick and Tired - Incline Village Outbreak[36]
- 2000 Documentary, I Remember Me, directed by Kim A. Snyder[37]
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1
- 2012, Phoenix Rising - Dr Daniel Peterson (July 12)
- 2015, 2015 De osynliga -Seminarium om ME/CFS, Sweden 19 October
- 2017, Solve ME/CFS Initiative’s 2nd Annual Discovery Forum: Presentation by Dr. Dan Peterson
Online presence[edit | edit source]
See also[edit | edit source]
- Ampligen
- Sierra Internal Medicine
- 1984 Incline Village chronic fatigue syndrome outbreak
- Paul Cheney
- List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks
- Canadian Consensus Criteria
Learn more[edit | edit source]
- Wikipedia - Daniel Peterson (physician)
- 1990, Chronic Fatigue Syndrome
- 2019, A Town for People with Chronic Fatigue Syndrome - New Yorker - about Ampligen
References[edit | edit source]
- ↑ "Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising". Health Rising. Retrieved August 13, 2018.
- ↑ "Collaborators - Simmaron Research". Simmaron Research. Retrieved August 13, 2018.
- ↑ "About Us". Nevada Center for Biomedical Research. Retrieved April 13, 2022.
- ↑ "History of Changes for Study: NCT00215813 | Study of Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. April 8, 2010. Retrieved April 13, 2020.
- ↑ "Daniel L. Peterson, MD". Open Medicine Foundation. Retrieved April 1, 2019.
- ↑ "TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS". www.ncf-net.org. Retrieved August 13, 2018.
- ↑ "Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. Retrieved August 13, 2018.
- ↑ 8.0 8.1 "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
- ↑ 1first 2 first 1 first 3 first 2, "A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection"
- ↑ 1first 2 first 1 first 3 first 2, "Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome"
- ↑ 1first 2 first 1 first 3 first 2, "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen"
- ↑ Peterson, Daniel L. (January 1997). "Chronic Fatigue Syndrome and Disability". Journal of Chronic Fatigue Syndrome. 3 (4): 5–7. doi:10.1300/j092v03n04_02. ISSN 1057-3321.
- ↑ 1first 2 first 1 first 3 first 2, "Chronic Fatigue Syndrome and Cancer"
- ↑ Strickland, Paula S.; Levine, Paul H.; Peterson, Daniel L.; O'Brien, Karen; Fears, Thomas (January 2001). "Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California". Journal of Chronic Fatigue Syndrome. 9 (3–4): 3–14. doi:10.1300/j092v09n03_02. ISSN 1057-3321.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ Suhadolnik, Robert J.; Peterson, Daniel L.; Reichenbach, Nancy L.; Roen, Gail; Metzger, Melodie; McCahan, John; O'brien, Karen; Welsch, Suzanne; Gabriel, Jerome; Gaughan, John P.; McGregor, Neil R. (2004). "Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway". Journal of Chronic Fatigue Syndrome. 12 (1): 5–35. doi:10.1300/J092v12n01_02.
- ↑ 1first 2 first 1 first 3 first 2, "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus"
- ↑ 1first 2 first 1 first 3 first 2, "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome."
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ 1first 2 first 1 first 3 first 2, "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis"
- ↑ 1first 2 first 1 first 3 first 2, "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome"
- ↑ 1first 2 first 1 first 3 first 2, "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study"
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ 1first 2 first 1 first 3 first 2, "Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome."
- ↑ 1first 2 first 1 first 3 first 2, "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome"
- ↑ 1first 2 first 1 first 3 first 2, "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study."
- ↑ 1first 2 first 1 first 3 first 2, "Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations"
- ↑ Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
- ↑ 1first 2 first 1 first 3 first 2, "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics"
- ↑ Mandarano, Alexandra H.; Maya, Jessica; Giloteaux, Ludovic; Peterson, Daniel L.; Maynard, Marco; Gottschalk, C. Gunnar; Hanson, Maureen R.; Maureen Hanson (February 10, 2020). "Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations". Journal of Clinical Investigation. 130 (3): 1491–1505. doi:10.1172/jci132185.
- ↑ "Invest in ME Research - IIMEC4". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC7 International ME Conference 2012". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC8 International ME Conference 2013". Invest in ME Research. Retrieved February 4, 2020.
- ↑ CFS and the CDC's Failure to Respond: Primetime Live (1996), retrieved February 4, 2020
- ↑ I Remember Me, retrieved February 4, 2020